Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2012
08/07/2012US8236487 Tumor specific oligosaccharide sequences and use thereof
08/07/2012US8236351 Tamper-resistant oral opioid agonist formulations
08/07/2012US8236347 Pharmaceutical compositions for reducing amyloid deposition, amyloid neurotoxicity, and microgliosis
08/07/2012US8236346 Method for reducing amyloid deposition, amyloid neurotoxicity, and microgliosis with (-)-nilvadipine enantiomer
08/07/2012US8236345 Composition and use
08/07/2012US8236340 Drug formulations for coating medical devices
08/07/2012US8236339 Therapeutic delivery of carbon monoxide
08/07/2012US8236331 Cosmetic cooling composition
08/07/2012US8236330 Cancer cell targeting using nanoparticles
08/07/2012US8236328 Pharmaceutical compositions of dispersions of amorphous drugs mixed with polymers
08/07/2012US8236321 Chemically programmable immunity
08/07/2012US8236303 Use of β-1,3 (4)-endoglucanohydrolase, β-1,3 (4) glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function
08/07/2012US8236292 Low viscosity, non-liquid crystalline mixture comprising tocopherol, diacyl glycerol and phosphatidyicholine for use in treatment of abrasions, oral and genital infections
08/07/2012US8236285 aerosol sprays; fast onset of effect
08/07/2012US8236282 Benzothiazole derivative compounds, compositions and uses
08/07/2012US8236048 Drug/drug delivery systems for the prevention and treatment of vascular disease
08/07/2012US8235935 Device and method for producing therapeutic foam
08/07/2012CA2683980C Topical composition comprising n-acetylaldosamines or n-acetylamino acids
08/07/2012CA2656915C Human protein tyrosine phosphatase inhibitors and methods of use
08/07/2012CA2649940C Drugs and uses to modulate inflammation, metabolic disorders and other conditions
08/07/2012CA2642465C Novel pyrone-indole derivatives and process for their preparation
08/07/2012CA2606861C Stable nanoparticle formulations
08/07/2012CA2601904C Antibacterial 3',5-disubstituted 2,4'-dihydroxybiphenyl compounds, derivatives and related methods
08/07/2012CA2600973C .delta.-amino-.gamma.-hydroxy-.omega.-aryl-alkanoic acid
08/07/2012CA2568897C Saturated and unsaturated 3-pyridyl-benzocycloalkylmethyl-amines for use in the treatment of pains, depressions and anxiety states
08/07/2012CA2566219C Substituted cyclohexyl-1,4-diamine derivatives with a chain extension
08/07/2012CA2565213C Use of 7-t-butoxyiminomethylcamptothecin for the preparation of a medicament for the treatment of uterine neoplasms
08/07/2012CA2563401C Imidazole derivatives used as tafia inhibitors
08/07/2012CA2559755C Dietary supplement and method for treating digestive system-related disorders
08/07/2012CA2553827C New combinations of an anti emetic agent and an enkephalinase inhibitor
08/07/2012CA2550187C Non-nucleoside reverse transcriptase inhibitors
08/07/2012CA2548666C Amino-benzimidazoles derivatives as inhibitors of respiratory syncytial virus replication
08/07/2012CA2548654C Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
08/07/2012CA2543249C Phenyl derivatives as ppar agonists
08/07/2012CA2533181C Use of dapsone as neuroprotector in the brain stroke
08/07/2012CA2529475C Medicament sustained-release particles and method for preparing the same
08/07/2012CA2514992C Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases
08/07/2012CA2514930C Caprazene as a novel compound and derivatives thereof, and caprazol as a novel compound and derivatives thereof
08/07/2012CA2513544C An otorhinological delivery device
08/07/2012CA2509365C Compositions and methods of delivery of pharmacological agents
08/07/2012CA2489270C A method of treating human skin and a skin care composition for use in such a method
08/07/2012CA2487566C Inhibitors of adp-ribosyl transferases, cyclases, and hydrolases
08/07/2012CA2484265C Method and device for controlling drug pharmacokinetics
08/07/2012CA2477737C Multi-substituted selective androgen receptor modulators and methods of use thereof
08/07/2012CA2457414C Virus coat protein/receptor chimeras and methods of use
08/07/2012CA2456516C Identification of a dna variant associated with adult type hypolactasia
08/07/2012CA2450087C Benzisoselenazolonyl derivatives having antineoplastic, anti-inflammatory and antithrombotic activities as well as their use
08/07/2012CA2447367C Diagnosis and treatment of malignant neoplasms
08/07/2012CA2445421C Von willebrand factor (vwf)-cleaving protease
08/07/2012CA2438314C 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
08/07/2012CA2430557C Highly branched soluble glucose polymers and process of obtaining same
08/07/2012CA2429216C Novel use of combined 5-ht1a agonists and selective serotonin reuptake inhibitors
08/07/2012CA2319715C Breast cancer resistance protein (bcrp) and the dna which encodes it
08/07/2012CA2317721C Novel steroid-activated nuclear receptors and uses therefor
08/07/2012CA2217251C Enhancing and stabilizing agent of the activity of bifidus factor
08/03/2012DE202012006847U1 Alkohol enthaltende Zusammensetzung Alcohol-containing composition
08/02/2012WO2012103524A2 Inhibitors of mtor kinasa as anti- viral agents
08/02/2012WO2012103523A2 Novel modulators of development of adipocyte and cancer cells
08/02/2012WO2012103520A1 Methods and compositions for modulating cyclophilin d
08/02/2012WO2012103493A1 Benzopyran compounds as melanogenesis modifiers and uses thereof
08/02/2012WO2012103487A1 Coumarin compounds as melanogenesis modifiers and uses thereof
08/02/2012WO2012103471A1 Use of potassium channel blockers to treat cerebral palsy
08/02/2012WO2012103457A2 Stilbene analogs and methods of treating cancer
08/02/2012WO2012103456A2 Polycyclic beta lactam derivatives for the treatment of cancer
08/02/2012WO2012103455A1 Biomarkers and their uses in cancer detection and therapy
08/02/2012WO2012103421A1 Adjuvant nanoemulsions with crystallisation inhibitors
08/02/2012WO2012103411A2 Controlled-release melatonin composition and related methods
08/02/2012WO2012103398A2 Methods for treating obstructive sleep apnea
08/02/2012WO2012103377A1 Remedy for migraine headache
08/02/2012WO2012103336A1 Small molecule rnase inhibitors and methods of use
08/02/2012WO2012103333A1 Tetrazole compounds and methods of making and using same
08/02/2012WO2012103328A1 Labeled, non- peptidic multivalent integrin alpha -v - beta - 3 antagonists, compositions containing them and their use
08/02/2012WO2012103314A1 Methods of treating tachycardia and/or controlling heart rate while minimizing and/or controlling hypotension
08/02/2012WO2012103305A1 Use of (s) - esmolol for controlling venous irritation associated with the treatment of a cardiac disorder
08/02/2012WO2012103297A1 COMPOUNDS FOR THE REDUCTION OF β-AMYLOID PRODUCTION
08/02/2012WO2012103295A2 Small molecule rnase inhibitors and methods of use
08/02/2012WO2012103276A1 Combinations
08/02/2012WO2012103226A2 Bendamustine formulations
08/02/2012WO2012103186A2 Androgen composition for treating an opthalmic condition
08/02/2012WO2012103163A2 Compositions and methods for treating cancer while preventing or reducing cardiotoxicity and/or cardiomyopathy
08/02/2012WO2012103119A1 Compositions for administering rifalazil and other anti-tuberculosis agents in unit dosage form for oral administration
08/02/2012WO2012103116A1 Pulmonary administration of rifalazil and analogs thereof
08/02/2012WO2012103113A1 Pyrazine and imidazolidine derivatives and their uses to treat hepatitis c
08/02/2012WO2012103071A2 Compounds and compositions
08/02/2012WO2012103059A2 Bcl-2/bcl-xl inhibitors and therapeutic methods using the same
08/02/2012WO2012103058A1 Method for synthesizing glucans with beta-1,3 and beta-1,6 linkages
08/02/2012WO2012103044A1 Process for the preparation of 4-amino-3-chloro-5-fluoro-6-(substituted)picolinates
08/02/2012WO2012103042A1 Arylalkyl esters of 4-amino-6-(substituted phenyl)picolinates and 6-amino-2-(substituted phenyl)-4-pyrimidinecarboxylates and their use as herbicides
08/02/2012WO2012103037A1 Oil compositions
08/02/2012WO2012103028A2 Methods and compositions for preparing noribogaine from voacangine
08/02/2012WO2012103015A2 Extended-release beta agonist/steroid transdermal patches and methods for using the same
08/02/2012WO2012103008A1 Histone deacetylase inhibitors and compositions and methods of use thereof
08/02/2012WO2012102985A1 Isoquinoline compounds and methods for treating hiv
08/02/2012WO2012102965A1 4-ANILINOFURO[2,3-b]QUINOLINE DERIVATIVES, THEIR PREPARATION PROCESSES, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
08/02/2012WO2012102937A2 Compounds that expand hematopoietic stem cells
08/02/2012WO2012102936A1 Highly penetrating compositions and methods for treating pathogen-induced disordered tissues
08/02/2012WO2012102832A1 Treatment of autism spectrum disorderes using glycyl-l-2-methylprolyl-l-glutamic acid
08/02/2012WO2012102793A2 Mammalian genes involved in toxicity and infection
08/02/2012WO2012102583A1 Pharmaceutical composition comprising pyridone derivatives
08/02/2012WO2012102580A1 Pharmaceutical composition comprising pyridone derivatives
1 ... 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 ... 7860